Most Popular Stories
Featured Jobs
-
NP or PA Job in California
StaffPointe, LLC - near Riverside, CA -
Nurse Practitioner - Peds 564
AVA Search Group - Eastern, NC -
Noninterventional Cardiologist Job for IN
StaffPointe, LLC - Indianapolis, IN -
Occupational Medicine Job in Indiana
StaffPointe, LLC - Indianapolis, IN -
Physician Recruiter Job Nationwide
StaffPointe, LLC - Nationwide
Events
- Harvard Business School 7th Healthcare Conference
January 30, 2010 - Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- health reform
- prescription drugs
- pharmaceutical companies
CA bill would let pharmacies sell patient prescription data
A new California bill working its way through the state Senate would allow pharmacies there to sell patient prescription information to third-party marketing firms working for pharmaceutical companies. The legislation, which is expected to pass the Senate, would let pharmas send mailings directly to patients. The bill's supporters say that the intent of the mailings would be to remind patients to take their meds and order refills.
It's worth noting, by the way, that this goes well beyond the so-called "data mining" that already routinely takes place in most states (other than those that have banned the practice). In those cases, pharmaceutical industry intermediaries like IMS Health collect data on physician prescribing patterns. Pharmas buy the data from IMS and its peers, then go out to the practices to sell doctors using the knowledge they've gained of that doctor's prescribing patterns. This, on the other hand, is a direct-to-consumer communications initiative.
Opponents like the Consumer Federation of California contend that the bill would allow the pharmas to intrude into consumers' private lives. The California Medical Association also opposes the measure, contending that it could harm patient safety and physician-patient relationships, particularly in the case of patients with sensitive medical issues like mental illnesses. Supporters, however, say they've addressed this issue by allowing people to opt out of the mailings when they go to pick up their prescriptions.
To learn more about the bill:
- read this San Francisco Chronicle piece
Related Articles:
WA attempts prescription data mining ban
Fight continues over state limits on prescription data mining
Data providers challenge prescription-privacy laws
Related Stories
- Trend: States try to counter pharma drug marketing
- MA leaders seek crackdown on medication abuse
- Senators plan bill countering pharma detailing tactics
- Studies show problems with four big-name drugs
- Louisiana MDs win legal battle over patient record disclosure
- FTC: Pharmas cut 14 deals to delay generic sales in '07
- Study: Some physicians uninformed about approved uses of drugs
- MD leaked Avandia results to GSK
- Biotechs eager for FDA approval of biogeneric drugs
- WA attempts prescription data mining ban
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





